维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="DENIS LJ"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Matrix metalloproteinase inhibitors:present achievements and future prospects显示文摘	Denis LJ Verweij J		0，，：	2
2	Oral paclitaxel and concurrent cyclosporin A : targeting clinically relevant systemic exposure to paclitaxel 显示文摘	Britten CD Baker SD Denis LJ	2000	Clin Cancer Res2000，6，9：	1
3	Matrix metalloproteinase inhibitors: present achievements and future pospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
4	Matrix metalloproteinase inhibitors: present achievements and future prospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
5	Goserelin acetate and flutamide versus bilateral orchiectomy: A Phase Ⅲ EORTC trial (30853)显示文摘	Denis LJ Whelan p Carneriro de Moura JL	1993	Urology1993，42，：	1
6	Estrogens and aspects of prostate disease显示文摘	Prezioso D Denis LJ Klocker H	2007	Int J Urol2007，14，：	1
7	Phase Ⅰ and pharmacokinetic study of XRP6258 (RPR 116258A),a novel taxane,administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors显示文摘	Mita AC Denis LJ Rowinsky EK	2009	Clin Cancer Res2009，15，2：	1
8	Phase I and pharmacokinetic study of XRP6258 (RPR 116258A),a novel taxane,administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors显示文摘	MITA AC DENIS LJ ROWINSKY EK	2009	Clin Cancer Res2009，15，2：	1
9	Matrix metalloproteinase inhibitors: present achieve- ments and future pospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
10	Matrix metalloproteinase inhibitors:present achievements and future prospects显示文摘	Verweij J	1997	Invest New Drugs1997，15，：	1
11	Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel 显示文摘	Britten CD Baker SD Denis LJ	2000	Clin Cancer Res2000，6，9：	1
12	Goserelin acetate andflutamideversus bilateral orchiectomy: a phase III EORTC trial (30853)显示文摘	Denis LJ Carnelro de Moura JL Bono A	1993	Urology1993，42，2：	1
13	Matrix metralloproteinase inhibitors:present achievements and future prospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
14	Matrix metalloproteinase inhibitors: present achievements and future prospects 显示文摘	Verweij J	1997	Invest New Drugs1997，15，3：	1
15	The story of the European Ran-domized Study of Screening for Prostate Cancer显示文摘	Schroder FH Denis LJ Roobol M	2003	BJU Int2003，92，2：	1
16	Matrix metallopriteinase inhibitors: present achievements and future prospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
17	Phase I and phannacoki- ??netic study of XRP6258(P(?)R 116258A),a novel taxane,administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors显示文摘	Mita AC Denis LJ Rowinsky EK	2009	Clin Cancer Res2009，15，2：	1
18	Matrix metalloproteinase inhibitors:present achievements and future prospects显示文摘	Denis LJ Verweij J	1997	Invest New Drugs1997，15，3：	1
19	Endocrine treatment in prostate cancer 显示文摘	Denis LJ Griffiths K	2000	Semin Surg Oncol2000，18，1：	1
20	Matrix metalloproteinase inhibitors: present achievements and future prospects 显示文摘	Verweij J	1997	Invest New Drugs1997，15，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示